No Data
No Data
Appian, Lions Gate See Activist Investor Action
These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities.
QuidelOrtho(QDEL.US) 10% Shareholder Sells US$5.57 Million in Common Stock
$QuidelOrtho(QDEL.US)$ 10% Shareholder Carlyle Group Inc. sold 164.5K shares of common stock on Jul 16, 17, 2024 at an average price of $33.8543 for a total value of $5.57 million. This transaction
QuidelOrtho to Report Second Quarter 2024 Financial Results
QuidelOrtho Corporation (NASDAQ:QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine,
QuidelOrtho(QDEL.US) 10% Shareholder Sells US$4.81 Million in Common Stock
$QuidelOrtho(QDEL.US)$ 10% Shareholder Carlyle Group Inc. sold 150.44K shares of common stock on Jul 12, 15, 2024 at an average price of $31.9496 for a total value of $4.81 million. This transaction
QuidelOrtho(QDEL.US) 10% Shareholder Sells US$3.76 Million in Common Stock
$QuidelOrtho(QDEL.US)$ 10% Shareholder Carlyle Group Inc. sold 120.97K shares of common stock on Jul 10, 11, 2024 at an average price of $31.1159 for a total value of $3.76 million. This transaction
QuidelOrtho(QDEL.US) 10% Shareholder Sells US$2.54 Million in Common Stock
$QuidelOrtho(QDEL.US)$ 10% Shareholder Carlyle Group Inc. sold 83,754 shares of common stock on Jul 8, 9, 2024 at an average price of $30.3009 for a total value of $2.54 million. This transaction
No Data